Active	Status	Sponsor type	Region	Phase	Filter
3 Active 10 Inactive 13 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Fountzilas, George
GALAXIES LUNG-201, NCT05565378 / 2021-005115-32: A Platform Study of Novel Immunotherapy Combinations in Participants With Previously Untreated, Advanced/Metastatic Non-Small-Cell Lung Cancer	Recruiting	2	340	Europe, Japan, US, RoW	Pembrolizumab, Dostarlimab, GSK4057190, Belrestotug, EOS884448, GSK4428859A, Nelistotug, GSK6097608	GlaxoSmithKline, iTeos Therapeutics	Lung Cancer, Non-Small Cell	10/25	10/28
NCT04403984: Investigation of Genomic Alteration in Patients With Luminal A or Luminal B Subtypes	Active, not recruiting	N/A	750	Europe		Hellenic Cooperative Oncology Group	Breast Cancer	12/20	03/23
NCT04863768: Molecular Profiling of Colorectal Cancer	Recruiting	N/A	300	Europe	Gene panel	Hellenic Cooperative Oncology Group	Colorectal Cancer, Colon Cancer, Colon Adenocarcinoma	09/21	09/22